New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 11, 2014
11:31 EDTINO, SD, CREE, GNC, OREX, WTW, INVN, UBNT, AEGR, SANOptions with increasing implied volatility
Options with increasing implied volatility: INO AEGR UBNT INVN WTW OREX GNC CREE SD SAN
News For INO;AEGR;UBNT;INVN;WTW;OREX;GNC;CREE;SD;SAN From The Last 14 Days
Check below for free stories on INO;AEGR;UBNT;INVN;WTW;OREX;GNC;CREE;SD;SAN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 23, 2014
11:08 EDTINOHigh option volume stocks
Subscribe for More Information
10:49 EDTINVNInvenSense likely won part of motion gyro sensor in iPhone 6, says Pacific Crest
Subscribe for More Information
09:44 EDTINOInovio price target raised to $29 from $26 at Piper Jaffray
Subscribe for More Information
09:20 EDTINOInovio's VGX-3100 for cervical dysplasia shows positive Phase II results
Inovio Pharmaceuticals announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 associated with human papillomavirus types 16 or 18. Treatment with VGX-3100 resulted in histopathological regression of CIN2/3 to CIN1 or no disease, meeting the study's primary endpoint. The trial demonstrated clearance of HPV in conjunction with regression of cervical lesions. Robust T-cell activity was detected in subjects who received VGX-3100 compared to those who received placebo.
July 22, 2014
11:44 EDTWTWWeight Watchers August volatility elevated into Q2 and enrollment guidance
Weight Watchers August call option implied volatility is at 57, September is at 43, January is at 37; compared to its 26-week average of 44 according to Track Data, suggesting larger near term price movement into the expected release of Q2 results on July 30.
06:15 EDTSANBanco Bilbao wins auction to buy Catalunya Banc for EUR1.19B
The Management Commission of the Banking Restructuring Fund has accepted BBVAs bid in the competitive auction for the acquisition of Catalunya Banc S.A. As a consequence, BBVA has executed a sale and purchase agreement with FROB, by virtue of which FROB will sell up to 100% of the shares of Catalunya Banc to BBVA for the price of up to EUR1.19B. Closing of the sale and purchase transaction will be subject, among others, to the obtaining of the relevant administrative authorizations and approvals and to the effective closing of the transaction announced by Catalunya Banc to the market on July 17 whereby Catalunya Banc will transfer to an asset securitization fund a loan portfolio with a nominal value of EUR.6.4B.
July 21, 2014
10:31 EDTOREXHigh option volume stocks:
High option volume stocks: EZPW LCI STLD SIAL FL OREX CROX NIHD EXTR BBT
07:11 EDTINOInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
July 18, 2014
06:08 EDTCREENavigant: High-bay lighting market shifting to LEDs, DigiTimes reports
Navigant says LED luminaries and lamps for high-bay lighting applications is expected to reach $7B in annual revenues by 2021 from $2.6B in 2014, reports DigiTimes. Navigant says that falling prices and rising efficacy of LEDs will create a tipping point for the large-scale adoption of LEDs in this segment. Reference Link
July 17, 2014
10:12 EDTGNCGNC drops after analyst downgrades on sales concerns
Subscribe for More Information
10:00 EDTGNCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 21st Century Fox (FOXA) downgraded to Buy from Strong Buy at ISI Group... Charter (CHTR) downgraded to Hold from Buy at Jefferies... Covidien (COV) downgraded to Hold from Buy at Needham... Diageo (DEO) downgraded to Underweight from Neutral at JPMorgan... GNC Holdings (GNC) downgraded to Hold from Buy at Jefferies... International Game (IGT) downgraded to Market Perform from Outperform at BMO Capital... JAVELIN Mortgage (JMI) downgraded to Market Perform from Outperform at JMP Securities... Macquarie Group (MQBKY) downgraded to Underweight from Neutral at JPMorgan... PNC Financial (PNC) downgraded to Neutral from Buy at Compass Point... PetSmart (PETM) downgraded to Sector Perform from Outperform at RBC Capital... Rexam (REXMY) downgraded to Hold from Buy at Deutsche Bank.
08:08 EDTCREECree outlook has improved, says Wedbush
Subscribe for More Information
07:16 EDTGNCGNC Holdings downgraded to Hold from Buy at Jefferies
Jefferies downgraded GNC Holdings to Hold citing a slowdown in industry sales trends and risk of near-term earnings disappointments. The firm lowered its price target for shares to $39 from $50.
05:30 EDTGNCGNC Holdings downgraded to Hold from Buy at Jefferies
Subscribe for More Information
July 16, 2014
11:28 EDTSDLeon Cooperman gives 12 stock picks at CNBC conference
Subscribe for More Information
11:17 EDTINVNRosenblatt believes InvenSense won OIS for Galaxy Note 4
Subscribe for More Information
11:16 EDTSDCooperman lists Actavis, Citigroup, KKR among top-picks, CNBC says
Subscribe for More Information
08:00 EDTINVNInvenSense Orbotech look good into Q2 results, says Oppenheimer
Subscribe for More Information
06:11 EDTCREEIHS: Solar expectations in Brazil rise, DigiTimes reports
Subscribe for More Information
July 15, 2014
10:56 EDTAEGRFed calls small cap social media, biotech valuations 'stretched'
The Board of Governors of the Federal Reserve in its Monetary Policy Report dated today said valuation metrics in "some sectors" appear substantially stretched, "particularly those for smaller firms in the social media and biotechnology industries, despite a notable downturn in equity prices for such firms early in the year." A later part in the document reads, "Equity valuations of smaller firms as well as social media and biotechnology firms appear to be stretched, with ratios of prices to forward earnings remaining high relative to historical norms." The specific targeting of sectors by the Fed seems to be having an impact on stocks in the social media and biotech spaces. Shares of Yelp (YELP) are down over 5% to $67.51, while Twitter (TWTR) and Facebook (FB) are each down 2%. Celgene (CELG) and Amgen (AMGN) are leading the biotech space lower with pullbacks of greater than 1%.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use